Can the template be signed electronically?

Yes. Electronic signatures are legally enforceable in the United States under the ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted, provided intent, consent, attribution, and record retention requirements are met.

Do I need special authentication for sensitive data?

For PHI, stronger signer authentication and a Business Associate Agreement are recommended under HIPAA. Use two‑factor or platform authentication when handling protected health information to reduce risk.

When is notarization required?

Notarization is required for certain instruments (deeds, some affidavits). Verify specific document types with your state notary rules and include notarization steps where local law or institutional policy requires them.

What if names or IDs do not match?

Name or protocol‑ID mismatches can invalidate approvals or delay funding. Reconcile records before submission and maintain a clear audit trail of any corrections and who authorized them.

How long must I retain completed templates?

Retention depends on the document and law: IRS typically 3 years (IRC §6501(a)), HIPAA 6 years (45 CFR §164.530(j)), and sponsors may require longer; set retention policies accordingly.

How do I correct an executed template?

If errors are discovered after signing, document the correction with an amendment or addendum signed by the same authorized signers, or re‑execute the corrected template per sponsor and IRB guidance.

Electronic Signature
Templates
Miscellaneous
Research Field Trials Template

Research Field Trials Template

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

RESEARCH FIELD TRIALS AGREEMENT

Parties and Contact Information

Sponsor Name Sponsor Address Primary Contact (Sponsor) Field Operator Name Field Operator Address Primary Contact (Operator)

Effective Date:

Recitals

WHEREAS, Sponsor is engaged in research, development, or testing of plant, seed, soil, or agronomic products and seeks to conduct one or more field trials under controlled conditions located at specified trial sites managed by Field Operator; and

WHEREAS, Field Operator represents that it controls access to the trial site(s), possesses necessary equipment and personnel to conduct field work in accordance with accepted agronomic practices, and is willing to conduct the trial(s) subject to the terms set forth in this Agreement; and

WHEREAS, the parties desire to set forth their respective obligations, deliverables, data ownership, confidentiality obligations and payment terms for the field trial(s).

Scope of Work

Summary of Trial Objectives and Tasks Trial Location Plot Size and Configuration

Trial Start Date: Trial End Date:

Experimental Design and Data Collection Protocols Materials, Seed and Equipment Provided By

Responsibilities and Reporting

Sponsor Responsibilities Field Operator Responsibilities Reporting and Deliverables Schedule

Payment Terms

Total Payment Amount:

Payment Schedule

Invoice Submission Instructions:

Payment Due Within (days): Late Fee:

Term and Termination

Agreement Term Commences: Agreement Term Ends:

Termination for Convenience: Either party may terminate this Agreement upon written notice to the other party delivered at least days prior to the effective termination date.

Termination for Cause: Either party may terminate immediately for material breach that is not cured within 30 days after written notice of breach; termination does not relieve the breaching party of liability for damages or for obligations accrued prior to termination.

Confidentiality, Data Ownership and Publication

Confidential Information means any non-public technical, business, agricultural, or commercial information disclosed by one party to the other. Each receiving party shall hold Confidential Information in strict confidence and shall not disclose it to third parties except as permitted in this Agreement.

Duration of Confidentiality

Data Ownership: All raw field data produced under this Agreement shall be the property of unless otherwise agreed in writing. Sponsor is granted a non-exclusive license to use agronomic data for research and regulatory submissions consistent with confidentiality obligations.

Publication and Acknowledgement Rights

Compliance, Permits and Biosafety

Each party shall comply with all applicable laws, regulations and permits applicable to the conduct of field trials, including but not limited to permits for genetically modified organisms, pesticide use, and environmental protection. Field Operator shall maintain records demonstrating compliance and shall provide copies to Sponsor upon request.

Permits Attached Check if required permits are attached with this Agreement

Insurance and Indemnification

Insurance: Field Operator shall maintain commercial general liability insurance and, where applicable, product liability coverage with limits not less than USD and shall provide certificates of insurance upon request.

Indemnification: Each party shall indemnify, defend and hold harmless the other party from claims, losses or liabilities arising out of that party's negligence or willful misconduct in performing its obligations under this Agreement, subject to any limitations of liability set forth herein.

Governing Law and Miscellaneous

Governing Law: This Agreement shall be governed by and construed in accordance with the laws of the state of without regard to its conflict of laws principles.

Amendment: This Agreement may be amended only by a written instrument executed by authorized representatives of both parties.

Entire Agreement: This Agreement, including attachments and referenced exhibits, constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior and contemporaneous understandings, agreements, representations and warranties, both written and oral, with respect to such subject matter.

Additional Terms or Attachments

Sponsor:

By:

Date:

Field Operator:

By:

Date:

What the Research Field Trials Template Covers

Research Field Trials Template is a standardized document used to plan, document, and record field-based experiments, including objectives, sampling design, site locations, schedules, and safety protocols. It consolidates principal investigator details, contact information, study procedures, consent language, data-collection instruments, and risk-mitigation steps. The template supports IRB submissions, sponsor reporting, and consistent operational execution across sites while creating an auditable trail for monitoring, replication, and regulatory review.

Why a Template Matters for Field Trials

A Research Field Trials Template reduces administrative error, speeds IRB and sponsor review, and ensures consistent data collection across locations. Standardizing fields clarifies roles, documents informed-consent protections, and helps satisfy regulatory and funding requirements while supporting reproducible methods for publication and audits.

Who Typically Uses This Template

Typical users include principal investigators, study coordinators, institutional compliance staff, and sponsor project managers preparing multi-site field studies.

Academic research teams responsible for study design, IRB submissions, and data integrity across field sites.
Clinical or public‑health investigators coordinating participant consent, safety monitoring, and adverse event reporting.
Sponsor or funder compliance officers tracking milestone deliverables, budgeted activities, and audit-ready records.

Teams use the template to coordinate approvals, manage logistics, and maintain a consistent record for monitoring, reporting, and publication.

Core Sections to Include in a Professional Template

A complete Research Field Trials Template groups study identification, methods, safety, data handling, responsibilities, and approvals so reviewers and site staff can follow one consistent workflow.

Study Title

Full protocol title, version number, and a one-line summary. Include protocol ID and sponsor reference to avoid mismatched records during review and reporting.

Objectives

Precise primary and secondary objectives, measurable endpoints, and success criteria. Clear objectives reduce ambiguity during data analysis and IRB assessment.

Methods

Site locations, sampling plan, inclusion/exclusion criteria, and standard operating procedures. Specify equipment, calibration, and field measurement protocols for reproducibility.

Safety Plan

Risk assessments, participant protections, emergency contacts, and adverse-event reporting procedures. Document PPE, environmental hazards, and contingency plans for field settings.

Data Management

Data capture methods, storage locations, backup frequency, de-identification steps, and who controls access. Tie procedures to regulatory and sponsor retention requirements.

Approvals

IRB/ethics approvals, sponsor signoff, local site permissions, and required permits. Include signature blocks and dates for each approval authority.

Step‑by‑Step: Completing the Template

Follow this sequence to prepare a complete, review-ready Research Field Trials Template before distribution and filing.

01

Draft Study Details: Fill title, objectives, sites, and sampling plan before seeking review.
02

Attach Protocol Documents: Include SOPs, consent forms, instruments, and permit copies with the template.
03

Obtain Approvals: Submit to IRB and local authorities; capture approval dates and IDs.
04

Distribute to Sites: Share the final, signed template and store a master copy centrally.

How to Configure the Template Online

Configure conditional fields, routing, and authentication in your e‑form platform before sending to reduce signer confusion and errors.

Field \| Configuration	Type \| Value
Conditional sections	Show site-specific fields only when a site is selected.
Reviewer routing	Route to IRB admin then sponsor compliance automatically.
Signer authentication	Use email or SMS code; escalate to KBA for sensitive records.
Audit trail	Enable full event logging and PDF certificate on completion.

Where to Send or File the Completed Template

A completed template should be routed to oversight and recordkeeping locations to satisfy regulatory, sponsor, and institutional requirements.

IRB Office: Upload final package to institutional IRB records for approval and audit.
Sponsor Records: Send signed copy to sponsor or contract administrator for compliance.
Local Site File: Retain an executed copy at each field site for inspections.
Central Repository: Store master PDF and audit trail in secure records system.

Distribution Channels and Integration Options

Choose distribution methods that preserve document integrity and capture a tamper‑evident audit trail before sharing with signers.

Cloud storage: Google Workspace, Box, or Egnyte integration for secure archival.
Clinical systems: Connectors to electronic data capture or EHR systems where allowed.
Collaboration: Use team access controls and versioning for multi-site coordination.

Typical Timelines and Submission Deadlines

Field trials follow a sequence of deadline-driven steps; missing an approval or reporting date can suspend study activity or affect funding.

IRB submission deadline:

Submit complete package before any participant contact or field activity.

Start of enrollment:

Do not begin enrollment until IRB and sponsor approvals are documented.

Interim reporting:

Provide scheduled safety and progress reports per sponsor or IRB schedule.

Final report:

Submit study closeout and final data summary as required by sponsor.

Retention actions:

Ensure record retention timelines are set before project closeout.

Common Preparation Mistakes to Avoid

Incomplete consent language or missing HIPAA authorization clauses delaying IRB approval and enrollment.
Mismatched names or protocol IDs between sponsor documents and site paperwork causing administrative rework.
Undefined data-storage locations or access controls raising data-protection and audit concerns.
Failing to document local permits or landowner permissions, which can halt field activities immediately.

Key Risks and Potential Consequences

HIPAA violation: Civil or criminal penalties, corrective action required.

IRB noncompliance: Study suspension or reporting obligations to regulators.

Data loss: Invalidated results and potential funding repercussions.

Contract breach: Sponsor remedies or withholding of payments.

Legal liability: Participant harm can trigger civil claims.

Recordkeeping failures: Audit findings and reputational damage.

Required Core Information Fields

Project Title: Full protocol name

Principal Investigator: Name and institution

Study Sites: List of locations

Sample Size: Planned enrollment count

Trial Dates: Start and end dates

Contact Info: Phone and email

eSignature Vendor Comparison for Field‑Trial Workflows

Comparing common eSignature plans can help teams choose an option that meets HIPAA, audit trail, and bulk distribution needs for multi‑site trials.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	Yes, 7-day trial	No	No	Yes, limited	Yes, limited
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes

Who Can Sign This Template

Principal Investigator

The PI signs to attest to study conduct and oversight. The PI’s signature confirms responsibility for protocol adherence, reporting obligations, and safety monitoring; institutions often require an authorized institutional official to countersign for contractual or financial commitments.

Authorized Official

An institutional official or sponsor representative with delegated authority must sign for contractual acceptance, funding commitments, or regulatory attestations; their signature carries institutional accountability for compliance and resource allocation.

FAQs and Troubleshooting

Answers to common questions about using, signing, and storing the Research Field Trials Template in U.S. regulatory contexts.

Need help? Contact support

Can the template be signed electronically?
Yes. Electronic signatures are legally enforceable in the United States under the ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted, provided intent, consent, attribution, and record retention requirements are met.
Do I need special authentication for sensitive data?
For PHI, stronger signer authentication and a Business Associate Agreement are recommended under HIPAA. Use two‑factor or platform authentication when handling protected health information to reduce risk.
When is notarization required?
Notarization is required for certain instruments (deeds, some affidavits). Verify specific document types with your state notary rules and include notarization steps where local law or institutional policy requires them.
What if names or IDs do not match?
Name or protocol‑ID mismatches can invalidate approvals or delay funding. Reconcile records before submission and maintain a clear audit trail of any corrections and who authorized them.
How long must I retain completed templates?
Retention depends on the document and law: IRS typically 3 years (IRC §6501(a)), HIPAA 6 years (45 CFR §164.530(j)), and sponsors may require longer; set retention policies accordingly.
How do I correct an executed template?
If errors are discovered after signing, document the correction with an amendment or addendum signed by the same authorized signers, or re‑execute the corrected template per sponsor and IRB guidance.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now